• Home
  • Search Results
  • Human adenovirus type 26 uses sialic acid-bearing glycans as a primary cell entry receptor.

Human adenovirus type 26 uses sialic acid-bearing glycans as a primary cell entry receptor.

Science advances (2019-09-14)
Alexander T Baker, Rosie M Mundy, James A Davies, Pierre J Rizkallah, Alan L Parker
ABSTRACT

Adenoviruses are clinically important agents. They cause respiratory distress, gastroenteritis, and epidemic keratoconjunctivitis. As non-enveloped, double-stranded DNA viruses, they are easily manipulated, making them popular vectors for therapeutic applications, including vaccines. Species D adenovirus type 26 (HAdV-D26) is both a cause of EKC and other diseases and a promising vaccine vector. HAdV-D26-derived vaccines are under investigation as protective platforms against HIV, Zika, and respiratory syncytial virus infections and are in phase 3 clinical trials for Ebola. We recently demonstrated that HAdV-D26 does not use CD46 or Desmoglein-2 as entry receptors, while the putative interaction with coxsackie and adenovirus receptor is low affinity and unlikely to represent the primary cell receptor. Here, we establish sialic acid as a primary entry receptor used by HAdV-D26. We demonstrate that removal of cell surface sialic acid inhibits HAdV-D26 infection, and provide a high-resolution crystal structure of HAdV-D26 fiber-knob in complex with sialic acid.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
N-Acetylneuraminic acid, from Escherichia coli, ≥98%